Lung Cancer Foundation of America

🇺🇸 An estimated 900,000 Veterans are eligible for lung cancer screening. Screening only helps if people know it’s there. If you served, or you love someone who did, share this. It could lead to the screening they’ve earned. 🎗️ Check eligibility: bit.ly/4e9SJd3

My friend Lori would have been 68 yesterday. In 2001, she was diagnosed with stage 4 lung cancer. Her doctor told her that her cancer was inoperable. Being a nurse, and knowledgeable about patient care, she didn’t stop at a second opinion – she got a third, then a fourth… She saw that lung cancer was the leading cause of cancer death, and she also saw that despite that, research for lung cancer was underfunded. Using her southern charm along with her knowledge from being a nurse and a patient, she went head to head with politicians and public leaders to advocate for lung cancer to get the attention and funding it deserved. So in 2007, we co-founded Lung Cancer Foundation of America together with David Sturges, another patient advocate. Our mission today is the same: to improve survival for people with lung cancer by funding transformative science. I hope she can see the researchers we've funded and the cumulative impact of the chances we took on those bright, bold, young minds. Lori also gave her time and attention to anyone who needed it, from patients to caregivers and gave them hope. When Lori was diagnosed, she hoped to see her daughters graduate high school. She saw them graduate college and danced at her youngest daughter’s wedding. She passed away too soon in 2013. We’re still funding lung cancer research - for Lori, for everyone like her, for everyone who has and loves the “Lori” in their life. We miss you. - Kim Norris, President of Lung Cancer Foundation of America

Veteran and lung cancer survivor Michelle has been on a targeted therapy since 2018. LCFA-funded researcher Dr. Jaime Schneider is studying why treatments like hers can stop working. #LCAM2026 Learn more: bit.ly/4knclOs #LungCancer

Today on National Lung Health Day, #crypto donors just pushed LCFA past $1M in crypto gifts! We cannot thank you enough. $1M = years of funded lung cancer research. Our grants have drawn 13X return in follow-on research funding. More time for researchers = more time for patients = more Halloweens with their kids, more game nights with friends, more time to spend with people we love. donate.gg/charities/lung-can… @donatedotgg

For Stephanie Williams, more options mean book fairs and Halloween parties with her daughter. Meanwhile, researchers like Dr. Jaime L. Schneider are finding out why some lung cancers stop responding to treatment. Learn more about the science of more optoins as we head into lung cancer awareness month: bit.ly/44vOl1T #LungCancerAwarenessMonth #LungCancerResearch #ALKPositive #LivingWithLungCancer #LCAM2026

November’s almost here. 🤍 This #LungCancerAwarenessMonth, we stand with Veterans, who face higher risk from service exposures. 🎗️ Wear white (+ red/blue for Vets) 🩻 See if you qualify for free screening 📣 Post your ribbon w/ #WhiteRibbonProject. 🇺🇸🤍 #BreathOfHonor lcfamerica.org/get-involved/…

What is PD-L1, and why does it matter for lung cancer treatment? Survivor Jane Perlmutter and host James Hiter explain how it guides immunotherapy and what to ask your care team. 🎧: bit.ly/3UBYwkT #LungCancer

“It’s always worthwhile to ask.” On #AskMeAnything, James Hiter and Stephanie Williams talk patient to patient about IV vs. subcutaneous lung cancer treatment and how to bring it up with your doctor. bit.ly/489LwG9

A 90–120 minute infusion can become a 3–6 minute injection. Dr. Coral Olazagasti and patient host Jeanne Szurek talk switching from IV to SubQ: eligibility, side effects, and insurance. 🎧:bit.ly/4dKovwX #LungCancer

Diagnosed with SCLC at 28 in 2006. Still here, still advocating. Montessa Lee on why there’s new hope in small cell lung cancer. Listen to our latest podcast 🎧: bit.ly/3WlxWwP

Jane Perlmutter’s PD-L1 score came back at 20%, but immunotherapy worked for her anyway. Her story is on our Ask Me Anything podcast. 🎧 Make it a double feature: 1️⃣ Start with Hope With Answers. Dr. Julie Brahmer and Colette Smith explain what a PD-L1 score is and what it means for lung cancer treatment. 2️⃣ Then listen to Ask Me Anything. Advocates Jane Perlmutter and James Hiter talk about the experience of immunotherapy based on PD-L1 scoring. Watch on YouTube or listen wherever you get podcasts. #LungCancer #PDL1 #BiomarkerTesting #Immunotherapy #LCFA

Immunotherapies, ADCs, combination therapies, SCLC subtypes: small cell lung cancer research is moving fast. Wendy Brooks and Dr. Ashish Saxena break it down on #HopeWithAnswers. bit.ly/3UDh5VS #SCLC #LCSM

"Communicate, communicate, communicate. Tell us how you’re feeling.” Dr. Olivia Fankuchen on why reporting skin side effects early helps lung cancer patients stay on treatment. bit.ly/4jvbs6j #LungCancer

Hidden Signs of lung cancer: 🫁 Losing 10+ lbs without trying 🫁 Bone pain that’s worse at night or with movement Have several of the 7 signs, for a while? Talk to your doctor about screening. bit.ly/4a4G1Hk #KnowTheSigns #LungCancerAwareness

Signs you feel: 🫁 Bronchitis or pneumonia that keeps coming back 🫁 Chest pain that’s worse when you breathe deeply, cough, or laugh Notice the pattern, then talk to your doctor. bit.ly/4a4G1Hk #KnowTheSigns